Home > Healthcare > Drug Device Combination > Drug Filled Devices > Hormone Replacement Therapy Market
Hormone Replacement Therapy Market size accounted for USD 21.8 billion in 2022 and is estimated to reach USD 40.1 billion by 2032 with a CAGR of 6.3% due to the increasing geriatric population, rising awareness of post-menopausal issues, increasing development of novel drug delivery systems for hormone imbalance issues, and rising prevalence of hormonal disorders.
Hormone Replacement Therapy (HRT) refers to a medical treatment that involves supplementing or replacing specific hormones in the body in order to treat hormonal deficiencies or imbalances. HRT is commonly used to alleviate symptoms and health issues that are associated with hormonal deficiencies or changes. HRT is widely used for various medical conditions such as menopause, hypothyroidism, testosterone deficiency, growth hormone deficiency, any many other conditions.
Report Attribute | Details |
---|---|
Base Year: | 2022 |
Hormone Replacement Therapy Market Size in 2022: | USD 21.8 Billion |
Forecast Period: | 2023 to 2032 |
Forecast Period 2023 to 2032 CAGR: | 6.3% |
2032 Value Projection: | USD 40.1 Billion |
Historical Data for: | 2018 to 2022 |
No. of Pages: | 165 |
Tables, Charts & Figures: | 288 |
Segments covered: | Product, Route of Administration, Disease Type, Distribution Channel, and Region |
Growth Drivers: |
|
Pitfalls & Challenges: |
|